One of the most exciting and clinically relevant observations was the discovery that a high percentage of glioma and a very small percentage of primary glioblastoma harbor mutations in the isocitrate dehydrogenase 1 (IDH1) gene. Here, IDH1 is linked to central nervous system cancer.